Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 362

1.

Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer.

Pinder MC, Duan Z, Goodwin JS, Hortobagyi GN, Giordano SH.

J Clin Oncol. 2007 Sep 1;25(25):3808-15. Epub 2007 Jul 30.

PMID:
17664460
2.

Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.

Doyle JJ, Neugut AI, Jacobson JS, Grann VR, Hershman DL.

J Clin Oncol. 2005 Dec 1;23(34):8597-605.

PMID:
16314622
3.

Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer.

Du XL, Xia R, Liu CC, Cormier JN, Xing Y, Hardy D, Chan W, Burau K.

Cancer. 2009 Nov 15;115(22):5296-308. doi: 10.1002/cncr.24621. Erratum in: Cancer. 2009 Dec 15;115(24):5849-51.

4.

Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.

Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, Taylor CW, van Leeuwen FE.

J Natl Cancer Inst. 2007 Mar 7;99(5):365-75.

PMID:
17341728
5.

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.

Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR.

J Natl Cancer Inst. 2007 Feb 7;99(3):196-205.

PMID:
17284714
6.

Use and outcomes of adjuvant chemotherapy in older women with breast cancer.

Giordano SH, Duan Z, Kuo YF, Hortobagyi GN, Goodwin JS.

J Clin Oncol. 2006 Jun 20;24(18):2750-6.

PMID:
16782915
7.

Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk.

Patt DA, Duan Z, Fang S, Hortobagyi GN, Giordano SH.

J Clin Oncol. 2007 Sep 1;25(25):3871-6. Epub 2007 Jul 30.

PMID:
17664457
8.

New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.

Ryberg M, Nielsen D, Cortese G, Nielsen G, Skovsgaard T, Andersen PK.

J Natl Cancer Inst. 2008 Aug 6;100(15):1058-67. doi: 10.1093/jnci/djn206. Epub 2008 Jul 29.

PMID:
18664656
9.

Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma.

Hershman DL, McBride RB, Eisenberger A, Tsai WY, Grann VR, Jacobson JS.

J Clin Oncol. 2008 Jul 1;26(19):3159-65. doi: 10.1200/JCO.2007.14.1242.

PMID:
18591554
11.

Cardioprotective effect of dexrazoxane in patients with breast cancer treated with anthracyclines in adjuvant setting: a 10-year single institution experience.

Testore F, Milanese S, Ceste M, de Conciliis E, Parello G, Lanfranco C, Manfredi R, Ferrero G, Simoni C, Miglietta L, Ferro S, Giaretto L, Bosso G.

Am J Cardiovasc Drugs. 2008;8(4):257-63.

PMID:
18690759
12.

Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.

Bowles EJ, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL, Habel LA, Yood MU, McCarty C, Magid DJ, Wagner EH; Pharmacovigilance Study Team.

J Natl Cancer Inst. 2012 Sep 5;104(17):1293-305. doi: 10.1093/jnci/djs317.

13.

Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy.

Baxter NN, Durham SB, Phillips KA, Habermann EB, Virning BA.

J Am Geriatr Soc. 2009 Mar;57(3):403-11. doi: 10.1111/j.1532-5415.2008.02130.x.

PMID:
19278395
14.

Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.

Shayne M, Crawford J, Dale DC, Culakova E, Lyman GH; ANC Study Group.

Breast Cancer Res Treat. 2006 Dec;100(3):255-62. Epub 2006 May 17.

PMID:
16705366
15.

Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment.

Harris EE, Correa C, Hwang WT, Liao J, Litt HI, Ferrari VA, Solin LJ.

J Clin Oncol. 2006 Sep 1;24(25):4100-6. Epub 2006 Aug 14.

PMID:
16908933
16.

Cardiac mortality in patients with stage I and II diffuse large B-cell lymphoma treated with and without radiation: a surveillance, epidemiology, and end-results analysis.

Pugh TJ, Ballonoff A, Rusthoven KE, McCammon R, Kavanagh B, Newman F, Rabinovitch R.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):845-9. doi: 10.1016/j.ijrobp.2009.02.045. Epub 2009 Jun 8.

PMID:
19515509
17.

Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer.

Hurria A, Hurria A, Brogan K, Panageas KS, Pearce C, Norton L, Jakubowski A, Howard J, Hudis C.

Drugs Aging. 2005;22(9):785-91.

PMID:
16156682
18.

Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke.

Woodward WA, Giordano SH, Duan Z, Hortobagyi GN, Buchholz TA.

Cancer. 2006 Jun 15;106(12):2556-62.

19.

Trastuzumab-related cardiotoxicity among older patients with breast cancer.

Chavez-MacGregor M, Zhang N, Buchholz TA, Zhang Y, Niu J, Elting L, Smith BD, Hortobagyi GN, Giordano SH.

J Clin Oncol. 2013 Nov 20;31(33):4222-8. doi: 10.1200/JCO.2013.48.7884. Epub 2013 Oct 14.

20.

Supplemental Content

Support Center